<DOC>
	<DOCNO>NCT01895634</DOCNO>
	<brief_summary>The main objective study document thrombectomy catheter ( Rev-01 ) effective safe use revascularization subject acute ischemic stroke within 8 hour symptom onset ineligible treatment IV t-PA , treatment IV t-PA ineffective .</brief_summary>
	<brief_title>Reperfuse Ischemic Vessels With Endovascular Recanalization Device JAPAN ( RIVER JAPAN )</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Key Subject present clinical sign symptom consistent diagnosis acute ischemic stroke Onset symptom within 8 hour prior treatment Rev01 Treatment IV tPA ineligible ineffective Occluded ( present TICI score 0 1 ) M1 M2 MCA , basilar vertebral artery , intracranial segment ICA , confirm angiography accessible Rev01 NIHSS score 830 Prior new focal disabling neurologic deficit , mRS score 02 Age 20 y.o . 85 y.o . Written inform consent participate subject legal representative Key Subject presenting ; ICA dissection , Angiitis , Arterial tortuosity would prevent device reach target vessel , Arterial stenosis &gt; 50 % would prevent device reach target vessel , Evidence acute intracranial hemorrhage , Evidence mass effect intracranial tumor , Evidence extend early ischemic change Subject two major artery occlude Known sensitivity ineligible radiographic agent , metallic allergy Administration dabigatran heparin within 48 hour precede onset stroke elevate APTT PTT twice normal range laboratory presentation Known bleed diathesis current use oral anticoagulant ( e.g. , warfarin sodium ) International Normalized Ration ( INR ) &gt; 3 Platelet count &lt; 30,000/mm3 Glucose &lt; 50 mg/dL Severe sustain hypertension ( SBP &gt; 185mmHG DBP &gt; 110mmHG ) refractory pharmacological management Life expectancy le 90 day Pregnancy females lactate Current participation investigational drug device study Otherwise determine investigator medically unsuitable participation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Ischemia</keyword>
	<keyword>Stroke</keyword>
	<keyword>Ischemic Stroke</keyword>
	<keyword>Thrombectomy</keyword>
	<keyword>Brain clot</keyword>
	<keyword>Cerebrovascular disease</keyword>
	<keyword>Recanalization</keyword>
	<keyword>Revascularization</keyword>
	<keyword>Clot Retriever</keyword>
	<keyword>Neurovascular Intervention</keyword>
	<keyword>Interventional Neuroradiology</keyword>
	<keyword>neurovascular clinical trial</keyword>
</DOC>